Search

For 2017, 26 EU/EEA Member States reported 409 646 cases of chlamydia infection.

For 2016, 1 102 cases of Q fever were reported in the EU/EEA, 1 058 (96%) of which were confirmed.

In 2017, 36 congenital syphilis cases were reported in 23 EU/EEA Member States, at a crude rate of 1.1 cases per 100 000 live births. The trend for reported congenital syphilis cases has remained stable in recent years.

For 2016, 1 148 cases of tularaemia were reported in the EU/EEA, 1 096 (95%) of which were confirmed.

This is the third report for the 2018–19 influenza season. As of week 1/2019, 18 049 influenza detections across the WHO European Region had been reported. Detections were made up of 97.7% type A viruses, with A(H1N1)pdm09 prevailing over A(H3N2), and 2.3% type B viruses, with 16 (64%) of 25 ascribed to a lineage being B/Yamagata.

Cholera is a rare travel-associated disease in the EU/EEA.

Legionnaires’ disease remains an uncommon and mainly sporadic respiratory infection with an overall notification rate in 2017 for the EU/EEA of 1.8 per 100 000.

In 2016, 29 EU/EEA countries reported 12 502 cases of hepatitis A, of which 12 429 (99.4%) were confirmed.

This expert consensus protocol for carbapenem resistance detection and characterisation was jointly developed by the EURGenCCRE consortium, the scientific advisory board for EURGen-Net and ECDC to agree upon the protocol for phenotypic and genotypic carbapenem resistance detection and confirmation to be used for the CCRE survey.